Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic Study of AVI-4020 in Cerebral Spinal Fluid Among Healthy Adult Males Following Intravenous Administration

NCT00387283 is registered in ClinicalTrials.gov with Sarepta Therapeutics, Inc. as lead sponsor.

NCT NCT00387283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00387283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic Study of AVI-4020 in Cerebral Spinal Fluid Among Healthy Adult Males Following Intravenous Administration
Lead sponsor
Sarepta Therapeutics, Inc.
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2006
Completion date
June 30, 2009
Enrollment
14
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

west nile virus